Abstract:The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of research into insulin action and resistance has issued. In the intervening century, some discoveries have matured, coalescing into solid and fertile ground for clinical application; others remain incompletely investigated and scientifically controversial. Here, we attempt to synthesize this work to guide further mechanistic investigation and to inform the development of novel therapies for type 2 diabetes (T2D). The rational development of such therapies necessitates detailed knowledge of one of the key pathophysiological processes involved in T2D: insulin resistance. Understanding insulin resistance, in turn, requires knowledge of normal insulin action. In this review, both the physiology of insulin action and the pathophysiology of insulin resistance are described, focusing on three key insulin target tissues: skeletal muscle, liver, and white adipose tissue. We aim to develop an integrated physiological perspective, placing the intricate signaling effectors that carry out the cell-autonomous response to insulin in the context of the tissue-specific functions that generate the coordinated organismal response. First, in section II, the effectors and effects of direct, cell-autonomous insulin action in muscle, liver, and white adipose tissue are reviewed, beginning at the insulin receptor and working downstream. Section III considers the critical and underappreciated role of tissue crosstalk in whole body insulin action, especially the essential interaction between adipose lipolysis and hepatic gluconeogenesis. The pathophysiology of insulin resistance is then described in section IV. Special attention is given to which signaling pathways and functions become insulin resistant in the setting of chronic overnutrition, and an alternative explanation for the phenomenon of ‟selective hepatic insulin resistanceˮ is presented. Sections V, VI, and VII critically examine the evidence for and against several putative mediators of insulin resistance. Section V reviews work linking the bioactive lipids diacylglycerol, ceramide, and acylcarnitine to insulin resistance; section VI considers the impact of nutrient stresses in the endoplasmic reticulum and mitochondria on insulin resistance; and section VII discusses non-cell autonomous factors proposed to induce insulin resistance, including inflammatory mediators, branched-chain amino acids, adipokines, and hepatokines. Finally, in section VIII, we propose an integrated model of insulin resistance that links these mediators to final common pathways of metabolite-driven gluconeogenesis and ectopic lipid accumulation.

Prolonged exposure to insulin might cause epigenetic alteration leading to insulin resistance

Changes in Cells Associated with Insulin Resistance

Diet induced insulin resistance is due to induction of PTEN expression

Insulin Signal Transduction Perturbations in Insulin Resistance

Cellular mechanism of insulin resistance: potential links with inflammation

Elevated Insulin Levels Compromise Endometrial Decidualization in Mice with Decrease in Uterine Apoptosis in Early-Stage Pregnancy.

Mice Endometrium Receptivity in Early Pregnancy is Impaired by Maternal Hyperinsulinemia

The aetiology and molecular landscape of insulin resistance

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat

Mechanisms of Insulin Action and Insulin Resistance

Prenatal High Estradiol Exposure Induces Sex-Specific and Dietarily Reversible Insulin Resistance Through Decreased Hypothalamic INSR

Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes

Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats

Epigenetics of Hepatic Insulin Resistance

In vitro characterization of the effects of chronic insulin stimulation in mouse 3T3-L1 and human SGBS adipocytes

Insulin Resistance is Mechanistically Linked to Hepatic Mitochondrial Remodeling in Nonalcoholic Fatty Liver Disease.

The role of insulin signaling in the development of β-cell dysfunction and diabetes

From hyperinsulinemia to cancer progression: how diminishing glucose storage capacity fuels insulin resistance

Insulin induces bioenergetic changes and alters mitochondrial dynamics in podocytes

Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes